Sanofi: the new protein-based Covid vaccine to be used in the UK

Protein-based vaccines have been safely used for years against hep B, flu and shingles

A lab technician at Sanofi’s world distribution centre in France
A lab technician at Sanofi’s world distribution centre in France
(Image credit: Joel Saget/AFP via Getty Images)

The University of Edinburgh’s Neil Mabbott on the vaccine technology being used for Covid booster jabs from this month.

In the UK a spring booster campaign has recently begun, offering an additional vaccine to people at highest risk from Covid. Between April and June 2023 people aged over 75, residents in care homes and children and adults aged five and up with weakened immune systems will be invited to get their next shot.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up